Associated Press | Federal regulators are investigating generic drugmaker Mylan Inc. over whether it disclosed confidential earnings information to a group of investors last September, according to The Wall Street Journal. Its shares fell more than 3 percent in morning trading.
Get the full story: Report: SEC is probing meeting drugmaker Mylan.
